[Clinical evaluation of serum pancreatic secretory trypsin inhibitor (PSTI) in patients with malignant diseases].
D000328:Adult; D000368:Aged; D002272:Carcinoembryonic Antigen / Q000032:analysis; D006801:Humans; D007674:Kidney Diseases / Q000201:enzymology; D008875:Middle Aged; D009369:Neoplasms / Q000201:enzymology*; D010179:Pancreas / Q000378:metabolism; D010182:Pancreatic Diseases / Q000201:enzymology; D010437:Peptic Ulcer / Q000201:enzymology; D014361:Trypsin Inhibitors / Q000097:blood*; D000509:alpha-Fetoproteins / Q000032:analysis
D002272:Carcinoembryonic Antigen; D014361:Trypsin Inhibitors; D000509:alpha-Fetoproteins